Oxysterol-induced soluble endoglin release and its involvement in hypertension
AC Valbuena-Diez, FJ Blanco, B Oujo, C Langa… - Circulation, 2012 - Am Heart Assoc
Background—Ischemia in the placenta is considered the base of the pathogenesis of
preeclampsia, a pregnancy-specific syndrome in which soluble endoglin (sEng) is a …
preeclampsia, a pregnancy-specific syndrome in which soluble endoglin (sEng) is a …
[HTML][HTML] Pulmonary vascular complications in hereditary hemorrhagic telangiectasia and the underlying pathophysiology
S Bofarid, AE Hosman, JJ Mager, RJ Snijder… - International journal of …, 2021 - mdpi.com
In this review, we discuss the role of transforming growth factor-beta (TGF-β) in the
development of pulmonary vascular disease (PVD), both pulmonary arteriovenous …
development of pulmonary vascular disease (PVD), both pulmonary arteriovenous …
[HTML][HTML] Structural and functional insights into endoglin ligand recognition and binding
A Alt, L Miguel-Romero, J Donderis, M Aristorena… - PloS one, 2012 - journals.plos.org
Endoglin, a type I membrane glycoprotein expressed as a disulfide-linked homodimer on
human vascular endothelial cells, is a component of the transforming growth factor (TGF)-β …
human vascular endothelial cells, is a component of the transforming growth factor (TGF)-β …
[HTML][HTML] Role of endoglin (CD105) in the progression of hepatocellular carcinoma and anti-angiogenic therapy
A Kasprzak, A Adamek - International Journal of Molecular Sciences, 2018 - mdpi.com
The liver is perfused by both arterial and venous blood, with a resulting abnormal
microenvironment selecting for more-aggressive malignancies. Hepatocellular carcinoma …
microenvironment selecting for more-aggressive malignancies. Hepatocellular carcinoma …
Neutral solution low in glucose degradation products is associated with less peritoneal fibrosis and vascular sclerosis in patients receiving peritoneal dialysis
K Kawanishi, K Honda, M Tsukada… - Peritoneal Dialysis …, 2013 - journals.sagepub.com
Background The effects of novel biocompatible peritoneal dialysis (PD) solutions on human
peritoneal membrane pathology have yet to be determined. Quantitative evaluation of …
peritoneal membrane pathology have yet to be determined. Quantitative evaluation of …
TGF-β/BMP proteins as therapeutic targets in renal fibrosis. Where have we arrived after 25 years of trials and tribulations?
JM Munoz-Felix, M Gonzalez-Nunez… - Pharmacology & …, 2015 - Elsevier
The understanding of renal fibrosis in chronic kidney disease (CKD) remains as a challenge.
More than 10% of the population of developed countries suffer from CKD. Proliferation and …
More than 10% of the population of developed countries suffer from CKD. Proliferation and …
[HTML][HTML] Endoglin regulates mural cell adhesion in the circulatory system
E Rossi, DM Smadja, E Boscolo, C Langa… - Cellular and Molecular …, 2016 - Springer
The circulatory system is walled off by different cell types, including vascular mural cells and
podocytes. The interaction and interplay between endothelial cells (ECs) and mural cells …
podocytes. The interaction and interplay between endothelial cells (ECs) and mural cells …
The choice of targets and ligands for site-specific delivery of nanomedicine to atherosclerosis
As nanotechnologies advance into clinical medicine, novel methods for applying
nanomedicine to cardiovascular diseases are emerging. Extensive research has been …
nanomedicine to cardiovascular diseases are emerging. Extensive research has been …
[HTML][HTML] Transcription factor KLF6 upregulates expression of metalloprotease MMP14 and subsequent release of soluble endoglin during vascular injury
E Gallardo-Vara, FJ Blanco, M Roqué, SL Friedman… - Angiogenesis, 2016 - Springer
After endothelial injury, the transcription factor Krüppel-like factor 6 (KLF6) translocates into
the cell nucleus to regulate a variety of target genes involved in angiogenesis, vascular …
the cell nucleus to regulate a variety of target genes involved in angiogenesis, vascular …
Resolution of inflammation pathways in preeclampsia—a narrative review
Preeclampsia (PE) is one of the leading causes of maternal morbidity and mortality
worldwide. This disease is believed to occur in two stages with placental dysfunction in early …
worldwide. This disease is believed to occur in two stages with placental dysfunction in early …